|
1992
LDF Conference Agenda -- Stamford, Ct
Return to Conference Archive
LYME
DISEASE: STATE OF THE ART CONFERENCE:
PRIMARY
CARE:
Diagnosis, Treatment, Patient Management
RESEARCH:
Microbiology, Immune Response, Pathogenesis, New Laboratory Diagnostics,
Vaccine Development
PUBLIC
HEALTH & VETERINARY MEDICINE:
Prevention, Control Measures, Regional Differences
Friday,
April 10,1992
- Welcome
The Honorable Stanley J. Esposito
Mayor, City of Stamford
- Keynote -
Lyme Disease: Facing the Issues
The Honorable Joseph I. Lieberman, JD
United States Senator
- Lyme Borreliosis:
The Global Perspective
Willy Burgdorfer, PhD, MD (Hon)
Discoverer of Borrelia burgdorferi, the causative agent
of Lyme disease
- Financial
Cost-to-Society of Lyme Borreliosis
Irwin Vanderhoof, PhD, FSA, CLU
Society of Actuaries
Stern School, New York University
- Lyme Disease:
New Education Techniques and Advocacy
Thomas E. Forschner, MBA, CPA
Executive Director, LBF
- Public Health
Programs - Aggressive Prevention
Andrew D. McBride, MD, MPH
Stamford Director of Health and Medical Advisor
- Front line
Diagnosis and Treatment in a Known Endemic Area
Joseph Burrascano, MD
Southampton Hospital, NIAID antigen study
- Neurologic
Manifestations in Children
Dorothy M. Pietrucha, MD
Cornell-New York Medical Center
Jersey Shore Medical Center
- Tissue Responses
and Pathology
Paul H. Duray, MD
Harvard Brigham and Women's Hospital
- Laboratory
Diagnostics ELISA, IFA, Western blot, Culturing
Louis A. Magnarelli, PhD
Connecticut Agricultural Experiment Station
- Use of PCR
for Molecular Diagnosis and Monitoring of Bb
David H. Persing, MD, PhD
Mayo Foundation
- New Laboratory
Diagnostic Tests on the Horizon
Tom Schwan, PhD
National Institutes of Allergy and Infectious Diseases, Rocky
Mountain Laboratories
- New Discoveries
about the Immune System's Response to Bb
- Cellular
Responses to Blebs Released by Bb
William Whitmire, PhD
LDF/Hartz Fellow
National Institutes of Allergy and Infectious Diseases, Rocky
Mountain Laboratories
- Escape Variants
of Bb: Selection with Antibodies
Ariadna Sadziene, MD
LBF/Hartz Fellow, University of Texas, San Antonio
Reception
- PUBLIC FORUM
Moderator
Derrick DeSilva, MD
Raritan Bay Medical Center
- John F. Anderson,
PhD
Connecticut Agricultural Experiment Station
Saturday, April 11,
1992
TRACK
A- PRIMARY CARE DIAGNOSIS & TREATMENT
- Tick-borne
Diseases and their Presentations
Michael Parry, MD
Infectious Disease Associates
Columbia University School of Medicine
- Family Practice
Diagnosis and Treatment in a Nonendemic Area
Edwin Masters, MD
St. Francis Hospital
- Dermatologic
Manifestations
Rudolph Scrimenti, MD
University of Wisconsin School of Medicine
First person to document Lyme borreliosis acquired in the
US
- Ophthalmologic
Manifestations of Lyme Disease
Robert Lesser, MD
Yale University School of Medicine
- Role of the
Infectious Disease Specialist
Debra Adler-Klein, MD
Infectious Disease Associates
Columbia University School of Medicine
- Lyme Borreliosis
Rheumatologic Manifestations and Treatment
Mori Schwartzberg, MD
Jersey Shore Medical Center
- Rheumatologic
Differential Diagnosis: Bb DNA in the Blood of 3 SLE Patients
Paul Lavoie, MD
University of California, San Francisco
- Treatment
Options
Bela Pal Bozsik, MD
National Institute of Hygiene, Hungary
- Blood Culturing:
Implications for Treatment and the Blood Supply
Ross Ritter, PA
Physicians Assistant
- Psychiatric
Presentations of Lyme Borreliosis
Brian Fallon, MD
New York State Psychiatric Institute
- Prophylactic
Treatment Controversy and Recommendations
Kenneth Liegner, MD
Internal and Critical Care Medicine
New York Medical College
- Treatment
Roundtable
James H. Katzel, MD
Family Practitioner
TRACK
B - RESEARCH
- Adhesion
to Host Cells by Bb
John Leong, MD, PhD
New England Medical Center
- Lyme Borreliosis
in C3H Mice and Implications for Pathogenesis
Kathleen Moody, VMD, MS
Yale University School of Medicine
- Immune Responses
in the Hamster
Ronald F. Schell, PhD
University of Wisconsin Medical School
- Canine as
an Animal Model and Vaccine Experience
Terri Wasmoen, PhD
Fort Dodge Laboratories
- Antigenic
and Immunogenic Components of Bb Antimicrobial Sensitivities
Russell C. Johnson, PhD
University of Minnesota
- Protective
Immunity in Mouse Model
Erol Fikrig, MD
Yale University School of Medicine
- Ribosomal
RNA Genes for Diagnosis and Phylogeny
Richard Marconi, PhD
Rocky Mountain Laboratories, National Institutes of Health
- High Level
Expression of Surface Proteins
John Dunn, PhD
Brookhaven Laboratory
- Chromosome
Mapping and Bb Genetic Variations
Isabelle Saint-Girons, PhD
Institut Pasteur, France
- Genetic Capacity
and Ultrastructure
Claude F. Garon, PhD
Rocky Mountain Laboratories
National Institutes of Health
- Spirochetal
Chaperonins
Peter Hindersson, MD
University of Copenhagen, Denmark
- Analysis
of Borrelia burgdorferi Motility
Stuart Goldstein, PhD
Department of Biologicals
University of Minnesota
- Surface Components
of Borrelia burgdorferi
Justin Radolf, MD
University of Texas, Dallas
TRACK
C - PUBLIC HEALTH & VETERINARY ISSUES
- Epizootiology
in the East: Vectors of Bb
John F. Anderson, PhD
Connecticut Agricultural Experiment Station
- Epizootiology
in the Far Western USA
Robert Lane, PhD
University of California, Berkeley
- Public Health
Issues of Borreliosis in the Southwest: Lyme vs. Relapsing Fever,
New Vectors
Julie Rawlings, MPH
Texas Department of Health
- Epizootiology
of Lyme Borreliosis in the Southeast
Gary Mullen, PhD
Auburn University
- Epizootiology
of Lyme borreliosis in the Midwest
Dorothy Feir, PhD
LBF/Hartz Grantee
St. Louis University
- Environmental
Risk Assessment and Control Strategies: I
Edward Bosler, PhD
New York State Department of Health
- Environmental
Risk Assessment and Control Strategies: II
Kirby Stafford, PhD
Connecticut Agricultural Experiment Station
- Spirochete
Vector Suppression Utilizing Acaricides for Topical and Systemic
Treatments of Wildlife
John George, PhD
United States Department of Agriculture
- Equine Borreliosis
Sandra Bushmich, MS, DVM
University of Connecticut
- Bovine Borreliosis
Sandra Bushmich, MS, DVM
University of Connecticut
- Canine Borreliosis
Steven Levy, VMD
Durham Veterinary Hospital
- Neuroborreliosis
in Canines: Expanding the Clinical Case Definition
Edward Schneider, PhD
Veterinary Research Associates
- Surveillance
using Canines
Pete Teel, PhD
Texas A&M University
- Development
of aSubunit Vaccine
Rance LeFebvre, PhD
University of California, Davis
- Vaccine Roundtable
Julie Rawlings, MPH
Texas Department of Health
-
|
